Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Insulin Delivery Device Market Dynamics Trends, Segmentation, Key Players, Application And ForecastThe insulin delivery device market size is projected to reach $15.6 billion by 2022, growing at a CAGR 6.6% between 2016-2022.
By: P&S Intelligence In terms of type, the insulin delivery device market (https://www.psmarketresearch.com/ Request for a sample of this research report: https://www.psmarketresearch.com/ Various initiatives, such as programs, activities and campaigns, are implemented by IDF, NGOs, diabetes associations and health departments to create awareness among people regarding effects of diabetes and correct method of treatment is driving the growth of the insulin delivery device market (https://www.psmarketresearch.com/ Continuous checking of glucose level is needed, in order to avoid risks associated with insulin delivery devices. In insulin pumps, the glucose level is checked continuously, so as to find if the tubing or cannula is disconnected or has blocked. It may lead to ketoacidosis, due to breakdown or absorption problem, skin infection at catheter site and has higher risk of hypoglycemia. Insulin pen needle has single use, although many diabetic patients re-use needle for delivery of insulin. The re-use of needle could lead to bacterial growth on the needle, risk of lipohypertrophy and risk of breaking fine tip of needle. Similarly, the risk associated with jet injectors are accuracy of insulin dosage and improper injection. Improper injection of insulin can lead to altered absorption level of insulin in the blood stream and bruising. Hence, these risks and complications associated with delivery devices are inhibiting the growth of the insulin delivery device market. Some of the key companies operating in the insulin delivery device market include Novo Nordisk A/S, Medtronic PLC, Abbott Laboratories, Eli Lilly and Company, Insulet Corporation, Sanofi S.A., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Animas Corporation, B. Braun Melsungen AG, and Ypsomed Holdings AG. Read Moreā¦ (https://www.psmarketresearch.com/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|